Brief: Spago Nanomedical Q3 Sales at SEK 271 Thousand

Spago Nanomedical AB (publ)

03/11/2023 07:08

Nov 3 (Reuters) - Spago Nanomedical Q3 operating expenses SEK -8.795 million.
* Q3 adjusted EPS SEK -0.08
* Q3 net income SEK -7.113 million
* Q3 sales SEK 271 thousand